Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Encephalitis, Tick-borne”

55 trials

Showing 20 of 55 results

Early research (Phase 1)Study completedNCT00118924
What this trial is testing

Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults

Who this might be right for
Tick-Borne Encephalitis
National Institute of Allergy and Infectious Diseases (NIAID) 28
Testing effectiveness (Phase 2)Study completedNCT00161772
What this trial is testing

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.

Who this might be right for
Tick-borne Encephalitis
Pfizer
Post-approval studies (Phase 4)Study completedNCT00311441
What this trial is testing

Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children

Who this might be right for
Encephalitis, Tick-Borne
Novartis 300
Large-scale testing (Phase 3)Study completedNCT00460486
What this trial is testing

Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 330
Not applicableUnknownNCT02463942
What this trial is testing

Tick-borne Encephalitis and Positive Borrelial Antibodies

Who this might be right for
Tick-borne Encephalitis
University Medical Centre Ljubljana 100
Testing effectiveness (Phase 2)Study completedNCT00161889
What this trial is testing

FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer 615
Post-approval studies (Phase 4)Study completedNCT02511535
What this trial is testing

TBE (Tick-borne Encephalitis) Vaccination in Allergic Patients

Who this might be right for
Vaccine Responsiveness in AllergyVaccine Responsiveness During Allergy De-sensitization Treatment
Medical University of Vienna 119
Large-scale testing (Phase 3)Study completedNCT00161863
What this trial is testing

Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

Who this might be right for
Tick-borne Encephalitis
Pfizer
Post-approval studies (Phase 4)Study completedNCT03294135
What this trial is testing

The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine

Who this might be right for
Virus Diseases
GlaxoSmithKline 194
Large-scale testing (Phase 3)Study completedNCT00161746
What this trial is testing

Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Not applicableLooking for participantsNCT07274046
What this trial is testing

Burden of Tick-borne Encephalitis and Cost-effectiveness of Vaccination in the Czech Republic

Who this might be right for
Tick Borne Encephalitis (TBE)
Charles University, Czech Republic 209
Large-scale testing (Phase 3)Study completedNCT00840801
What this trial is testing

Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 302
Post-approval studies (Phase 4)Study completedNCT01562444
What this trial is testing

Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules

Who this might be right for
Tick Borne EncephalitisVirus Diseases
GlaxoSmithKline 206
Large-scale testing (Phase 3)Study completedNCT01361776
What this trial is testing

Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Who this might be right for
Tick-borne Encephalitis
Sormland County Council, Sweden 200
Post-approval studies (Phase 4)Study completedNCT01106482
What this trial is testing

An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE

Who this might be right for
Tick Borne Encephalitis (TBE)
Novartis Vaccines 126
Early research (Phase 1)Not Yet RecruitingNCT07377253
What this trial is testing

First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers.

Who this might be right for
The Tick-borne Encephalitis Virus (TBEV)
Giuseppe Pantaleo 18
Large-scale testing (Phase 3)Study completedNCT04648241
What this trial is testing

Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older

Who this might be right for
Tick-Borne Encephalitis
Pfizer 165
Post-approval studies (Phase 4)Study completedNCT00894686
What this trial is testing

Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 179
Post-approval studies (Phase 4)Study completedNCT00161954
What this trial is testing

Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Post-approval studies (Phase 4)Study completedNCT00163540
What this trial is testing

Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation